Iniciar Sesión Regístrate abrir menu

Bibliografía Científica

Artículos por temáticas

En este apartado encontrará una actualización mensual de Trastornos del Movimiento

6082 ARTÍCULOS , VIENDO DEL 841 AL 855

Health economics of Parkinson's disease prevention: why early detection matters in low- and middle-income countries

Jamora RDG, Tabuzo-Acuin MMB, Ibrahim NM, Tsuboi Y.

J Neural Transm (Vienna). 2026 Sep 19. doi: 10.1007/s00702-026-03291-0. Online ahead of print.

Can Music-induced brain plasticity delay Neurodegenerative Disorders in Musicians? Review and Cases

Altenmüller E.

Neurodegener Dis. 2026 Sep 23:1. doi: 10.1159/ndd/aduag004. Online ahead of print.

Advances and challenges in electrochemical detection of α-synuclein: Toward precision diagnosis of Parkinson's disease

Cheng J, Xu XH, Chen H.

Bioelectrochemistry. 2026 Sep 21;174:109457. doi: 10.1016/j.bioelechem.2026.109457. Online ahead of print.

Dopamine-replacing gene therapy for Parkinson's disease: biochemical background and current clinical experience

Ichinose H, Sato Y, Muramatsu SI.

Expert Opin Biol Ther. 2026 Oct;26(10):1113-1124. doi: 10.1080/14712598.2026.2738706. Epub 2026 Sep 30.

Integration of cell-specific gene expression and chromatin accessibility facilitates localization of neurodegenerative risk in microglia

Reed X, Acri DJ, Beilina A, Ding J, Saez-Atienzar S, Kaileh M, Bromberek S, Hu F, Lerner G, Ramos DM, Solaiman S, Portley M, Weller CA, Whitaker DT, Ehrlich DJ, Ferrucci L, Scholz SW, Gibbs JR, Cookson MR.

bioRxiv [Preprint]. 2026 Sep 17:2026.09.15.751821. doi: 10.64898/2026.09.15.751821.

Upper Limb Exercises Reduce Non-motor Symptoms and Increase Cognitive Function in Parkinson's Disease: Randomized Controlled Trial

Costa V, Menacho M, Frigo da Rocha T, Fregni F, de Andrade LP, Gianlorenço AC.

J Geriatr Psychiatry Neurol. 2026 Sep;39(5):624-637. doi: 10.1177/08919887251409414. Epub 2025 Dec 26.

Cryo-EM Structures of Infectious Low-Twist α-Synuclein Filaments in Lewy Bodies

Yan NL, Mayer M, Melo AA, Ayers JI, Mordes DA, Seeley WW, Prusiner SB, Tse E, Chittoor-Vinod VG, Merz GE.

bioRxiv [Preprint]. 2026 Sep 17:2026.09.16.752119. doi: 10.64898/2026.09.16.752119.

Activity-dependent adaptive deep brain stimulation improves gait in Parkinson's disease

Scafa S, de Seta V, Wang R, Sánchez López P, Sánchez López A, Varescon C, Sakr I, Bérard N, Bole-Feysot L, Deschenaux C, Enderli I, Thenaisie Y, Burri M, Merlos F, Fleury V, Wicki B, Accolla E, Tziakouri A, Hübsch C, Castro Jiménez M, Bally JF, Puiatti A, Lee K, Lorach H, Collomb-Clerc A, Bloch J, Moraud EM.

Nat Med. 2026 Aug;32(8):2815-2830. doi: 10.1038/s41591-026-04432-4. Epub 2026 Jun 15.

Multitargeted drug strategies for Alzheimer's and Parkinson's diseases

Khan AU, Abdullah A, Naqvi SF, Tahir H, Khalid H, Sarfraz H, Khan Y.

Z Naturforsch C J Biosci. 2026 Aug 31. doi: 10.1515/znc-2026-0116. Online ahead of print.

GLP-1 and GIP class drugs have neuroprotective properties in Alzheimer's and Parkinson's disease

Hölscher C.

Front Neurosci. 2026 Aug 14;20:1906426. doi: 10.3389/fnins.2026.1906426. eCollection 2026.

Sex Differences in Levodopa-Sparing Effect of Safinamide: Post-hoc Findings from a Multicenter, Longitudinal, Case-Control Study

Cilia R, Cereda E, Colucci F, Piatti M, Bonvegna S, Pilotto A, Comi C, Mancini F, Zibetti M, De Micco R, Sensi MC, Ceravolo R, Zangaglia R, Di Fonzo A, Pellecchia MT, Modugno N, Sorbera C, Canesi M, Pistoia F, Eleopra R.

Mov Disord Clin Pract. 2026 Sep;13(9):2210-2215. doi: 10.1002/mdc3.70642. Epub 2026 Apr 21.

Plasma neurofilament light for early differentiation of multiple system atrophy from Parkinson disease

Yu Z, Zheng Y, Kou W, Cai H, Li S, Wu J, Yang C, Zhu B, Liu G, Wang Y, Tian H, Zhang X, Zhou Y, Liu X, Chang Y, Chen Z, Mao W, Feng T.

EBioMedicine. 2026 Sep;131:106461. doi: 10.1016/j.ebiom.2026.106461. Epub 2026 Aug 31.

Effects of basic and dual-task training programs on physical function in Parkinson's disease: The PARKEX study

Magaña JC, Enríquez-Calzada S, Prat R, Deus CM, Pereira SP, Avellanet M, Gea E, Laguna A, Martinez-Vicente M, Perez-Larumbe O, Giné-Garriga M, Hernández-Vara J, Montane J.

PLoS One. 2026 Sep 18;21(9):e0358534. doi: 10.1371/journal.pone.0358534. eCollection 2026.

Cannabis and Cannabinoids: The Medical Potential of Cannabidiol in Mental and Neurological Disorders

Șolea R, Șerban E, Călugăr-Solea SF, Mathe E, Blebea NM, Hancu G, Serban G.

Pharmaceuticals (Basel). 2026 Aug 6;19(8):1238. doi: 10.3390/ph19081238.

Not always the usual suspect: symptom variations in Parkinson's disease beyond ON-OFF fluctuations

Ebersbach G, Jost WH, Koschel J, Müller R, Paus S, Urban PP, Poewe W, Storch A.

J Neural Transm (Vienna). 2026 Aug 27. doi: 10.1007/s00702-026-03266-1. Online ahead of print.

Actualización mensual Regístrese para recibir los avisos de actualización

Si quiere recomendar un artículo/publicación para completar este apartado puede hacerlo a través del formulario de contacto para su valoración.

En ningún caso la información facilitada constituye asesoramiento por parte de Zambon

Con el aval de:

Logo SEN Logo WIS

En colaboración con:

Zambon Neurociencias